Indications: The OsteoMed 1st Metatarsal Phalangeal Joint (MTP) Hemi Implant System is intended for use in the treatment of patients with inflammatory arthritis in the first metatarsal joint in the presence of good bone stock and integrity of the first metatarsal head, along with the following clinical conditions: hallux valgus, hallux rigidus and an unstable or painful metatarsophalangeal joint. OsteoMed 1st MTP Joint Hemi Implant System implants are intended for single patient use only. Contraindications: Use of the OsteoMed 1st MTP Joint Hemi Implant System is contraindicated in cases of active or suspected infection or in patients who are immunocompromised; in patients previously sensitized to the implant material; in patients with certain metabolic diseases; or in patients exhibiting disorders which would cause the patient to ignore the limitations of artificial joint replacement. This system is further contraindicated in serious systemic diseases. The OsteoMed 1st MTP Joint Hemi Implant System should not be used in cases where the remaining bone is too diminished to provide adequate width or height to surround the implant. Implant failure may occur in cases where there is insufficient available bone or poor bone quality or in patients with blood supply limitations. Use of the implant is further contraindicated in cases of significant angular or biomechanical deformities or in cases which would subject the implants to excessive stress or wear due to patient weight and/or activity level.
|Document Title||Document Type||Language||Published||Updated|
|OsteoMed Hemi Great Toe Implant Surgical Technique (030-1504-B)||Surgical Technique||English EN||December 2, 2021||December 2, 2021|